| 摘要 |
<p>The present invention relates generally to the use of human IL-18, also known as interferon-????-inducing factor (IGIF), in the treatment of skin wounds, surgical wounds, leg ulcers, diabetic ulcers, gastrointestinal mucositis, oral mucositis, and lung injury.</p> |
